Quick Overview: Presenters respond to audience questions on CDER's Robert Lionberger, Kris Andre, Dale Conner, Kamal Tiwari, and Katherine Tyner answer audience questions. Presenters respond to audience questions. ----------------------------- FDA CDER's Small Business and Industry Assistance (SBIA) ...

Panel Discussion 31of39 Complex Generics - Detailed Overview & Context

Presenters respond to audience questions on CDER's Robert Lionberger, Kris Andre, Dale Conner, Kamal Tiwari, and Katherine Tyner answer audience questions. Presenters respond to audience questions. ----------------------------- FDA CDER's Small Business and Industry Assistance (SBIA) ... Liang Zhao, Yaning Wang, Robert Lionberger, and Murray Ducharme from Learn and Confirm, Inc., respond to audience ... Bryan Newman, Denise Conti, Kimberly Witzmann, Tian Ma, Fang Yuan, and Bhagwant Rege respond to audience questions. Kimberly Witzmann from the Office of Bioequivalence in CDER's Office of

Jane Chang from CDER's Office of Pharmaceutical Quality discusses Kelley Burridge, CDER Office of Pharmaceutical Quality (OPQ), discusses OPQ considerations and how to resolve ANDA ... Lisa Bercu, Regulatory Counsel in the Office of Thomas O'Connor, Changning Gou, Patricia Onyimba, Shin (Grace) Chou, Kshitij (Kris) Patkar and Melanie Mueller Caliope Sarago, Fang Yuan, Janice T. Brown and Lei Zhang

Photo Gallery

Panel Discussion (31of39) Complex Generics 2018
Final Panel Discussion – All Topics (39of39) Complex Generics 2018
Questions and Panel Discussion (9of39) Complex Generics 2018
Panel Discussion- Delivery/Dosage Forms: Topical and Transdermal (25of39) Complex Generics 2018
Panel Questions and Discussion (35of35) Complex Generics – Sep. 25-26, 2019
Panel Discussion - Delivery/Dosage Forms: Topical and Transdermal (28of39) Complex Generics 2018
Complex Generics: Topical Products, Part 1
Panel Questions and Discussion (28of35) Complex Generics – Sep. 25-26, 2019
Overview of Current Science-Based Regulatory Standards (21of39) Complex Generics 2018
Questions and Panel Discussion (20of39) Complex Generics 2018
Questions and Panel Discussion (5of39) Complex Generics 2018
Comparative Analyses: Device and User Interface (25of35) Complex Generics– Sep. 25-26, 2019
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored